Skip to contentSkip to main content
ResearchRank
RESEARCHER PUBLIC RESEARCH PROFILE● Verified public profile
RRK-A-5004-4434-63

Balraj Singh

The University of Texas MD Anderson Cancer Center
Works109
Citations2,395
h-index26
i10-index47
2-year citedness0.00
Mean FWCI*3.46
Top 1%*0
Top 10%*11
*Calculated from the leading research works available to the ResearchRank profile service.
IDORCID ▥Research data✓Verify credentials
ResearchRank IDRRK-A-5004-4434-63
Observed nameBalraj Singh
ORCID0000-0002-2985-5884
Current / last-known institutionThe University of Texas MD Anderson Cancer Center
Research topicsCancer Cells and Metastasis · Breast Cancer Treatment Studies · Inflammatory mediators and NSAID effects · Cancer, Hypoxia, and Metabolism · Protein Kinase Regulation and GTPase Signaling
Name variantsB Singh, B. SINGH, B. Singh, B.R. Singh, Balraj SINGH, Balraj Singh
FULL PROFILE ANALYSIS

Balraj Singh - detailed research intelligence

Identity, scholarly output, impact indicators, affiliations, topics and publication evidence for this ResearchRank record.

Profile typeResearcher
Works109
Citations2,395
h-index26
i10-index47
Current / last-known affiliationThe University of Texas MD Anderson Cancer Center
ORCID0000-0002-2985-5884
Name variantsB Singh, B. SINGH, B. Singh, B.R. Singh, Balraj SINGH, Balraj Singh
Primary research topics

Cancer Cells and MetastasisBreast Cancer Treatment StudiesInflammatory mediators and NSAID effectsCancer, Hypoxia, and MetabolismProtein Kinase Regulation and GTPase Signaling

Cancer Cells and MetastasisBreast Cancer Treatment StudiesInflammatory mediators and NSAID effectsCancer, Hypoxia, and MetabolismProtein Kinase Regulation and GTPase Signaling
RESEARCH ACHIEVEMENT SNAPSHOT

Evidence-backed profile highlights

This public profile presents scholarly evidence and recognition indicators without displaying certificate prices or checkout controls.

✓ Evidence threshold met

Verified Researcher Certificate

Active ResearchRank profile with at least one indexed scholarly output

✓ Evidence threshold met

Research Output Certificate

At least 10 indexed scholarly works

✓ Evidence threshold met

Citation Impact Certificate

At least 100 indexed citations

✓ Evidence threshold met

h-index Achievement Certificate

h-index of 10 or higher

✓ Evidence threshold met

Distinguished Researcher Certificate

h-index of 20+ and at least 1,000 indexed citations

✓ Evidence threshold met

Sustained Research Output Certificate

At least 50 indexed scholarly outputs

Public profile: Research metrics and recognition evidence are shown for professional sharing. Commercial pricing and registration controls are intentionally omitted.
Extended publication analytics and related-profile intelligence are loading in the background. The full profile details below remain available even if the live analytics service is temporarily slow.
TOP-CITED OUTPUT

Research works

Full profile view · up to 25 leading works
A CXCR4 Antagonist CTCE-9908 Inhibits Primary Tumor Growth and Metastasis of Breast CancerArticle · 2008 · 185 citations · FWCI 5.6282 · Full text ↗
COX-2 overexpression increases motility and invasion of breast cancer cellsArticle · 2005 · 173 citations · FWCI 9.3553 · Full text ↗
COX-2 involvement in breast cancer metastasis to boneArticle · 2007 · 144 citations · FWCI 5.7606 · Full text ↗
Important Role of FTO in the Survival of Rare Panresistant Triple-Negative Inflammatory Breast Cancer Cells Facing a Severe Metabolic ChallengeArticle · 2016 · 137 citations · Open access · FWCI 1.5264 · Full text ↗
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Reverses Mesenchymal to Epithelial Phenotype and Inhibits Metastasis in Inflammatory Breast CancerArticle · 2009 · 129 citations · Open access · FWCI 4.3267 · Full text ↗
Detection of minimal residual disease in blood and bone marrow in early stage breast cancerArticle · 2010 · 119 citations · Open access · FWCI 7.4205 · Full text ↗
Role of Cyclooxygenase-2 in Breast CancerReview · 2002 · 114 citations · FWCI 1.1 · Full text ↗
The cyclin B2 component of MPF is a substrate for the c-mosxe proto-oncogene productArticle · 1990 · 104 citations · Open access · FWCI 10.6342 · Full text ↗
HER2 status predicts the presence of circulating tumor cells in patients with operable breast cancerArticle · 2008 · 83 citations · Open access · FWCI 4.321 · Full text ↗
COX-2 Induces IL-11 Production in Human Breast Cancer CellsArticle · 2006 · 81 citations · FWCI 3.9669 · Full text ↗
Involvement of IL-8 in COX-2-Mediated Bone Metastases from Breast CancerArticle · 2006 · 74 citations · FWCI 3.9669 · Full text ↗
Maturatio of 5‐S rRNA: Ribonuclease E Cleavages and Their Dependence on Precursor SequencesArticle · 1983 · 61 citations · Open access · FWCI 2.0657 · Full text ↗
Role of COX-2 in Tumorospheres Derived from a Breast Cancer Cell LineArticle · 2010 · 58 citations · Open access · FWCI 2.0525 · Full text ↗
Cyclooxygenase-2 Induces Genomic Instability, BCL2 Expression, Doxorubicin Resistance, and Altered Cancer-Initiating Cell Phenotype in MCF7 Breast Cancer CellsArticle · 2008 · 51 citations · FWCI 4.6693 · Full text ↗
The role of c-mos proto-oncoprotein in mammalian meiotic maturation.Article · 1991 · 46 citations · FWCI 1.77 · Full text ↗
Applications of Circulating Tumor Cells and Circulating Tumor DNA in Precision Oncology for Breast CancersReview · 2022 · 45 citations · Open access · FWCI 1.0591 · Full text ↗
Evaluation of a CXCR4 antagonist in a xenograft mouse model of inflammatory breast cancerArticle · 2010 · 43 citations · FWCI 2.8419 · Full text ↗
Cyclooxygenase-2 expression in primary breast cancers predicts dissemination of cancer cells to the bone marrowArticle · 2008 · 36 citations · Open access · FWCI 3.035 · Full text ↗
Cox-2 overexpression increases motility and invasion of breast cancer cellsConference Abstract · 2004 · 35 citations · Full text ↗
Vimentin phosphorylation by p37mos protein kinase in vitro and generation of a 50-kDa cleavage product in v-mos-transformed cellsArticle · 1989 · 34 citations · FWCI 1.9863 · Full text ↗
Induction of N-acetylglucosamine-catabolic pathway in spheroplasts of Candida albicansArticle · 1979 · 33 citations · Open access · FWCI 0.8876 · Full text ↗
Disseminated tumor cells predict survival after neoadjuvant therapy in primary breast cancerArticle · 2011 · 32 citations · Open access · FWCI 1.0877 · Full text ↗
Regulation of n-acetylglucosamine uptake in yeastArticle · 1979 · 32 citations · FWCI 0.5326 · Full text ↗
Selection of Metastatic Breast Cancer Cells Based on Adaptability of Their Metabolic StateArticle · 2012 · 28 citations · Open access · FWCI 1.4233 · Full text ↗
Overexpression of COX-2 in Celecoxib-Resistant Breast Cancer Cell LinesArticle · 2010 · 26 citations · Open access · FWCI 1.643 · Full text ↗